Home › Germ Cell and Embryonal Cancer › New Jersey
Germ Cell and Embryonal Cancer clinical trials in New Jersey
4 studies for Germ Cell and Embryonal Cancer are looking for participants at sites in New Jersey.
Cities in New Jersey
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
- Hackensack University Medical Center, Hackensack
- Morristown Medical Center, Morristown
- Jersey Shore Medical Center, Neptune City
- and 4 more
RecruitingPhase 3
All ages · All sexes · Updated Aug 25, 2026 · NCT03067181Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors
- The John Theruer Cancer Center at Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 15 and older · All sexes · Updated Aug 25, 2026 · NCT06276491A Study of ZW251 in Participants With Advanced Solid Tumors
- Hackensack University Medical Center, Hackensack
RecruitingPhase 1
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT07164313Germ Cell Tumor and Testicular Tumor DNA Registry
- Memorial Sloan Kettering Basking Ridge, Basking Ridge
- Memorial Sloan Kettering Monmouth, Middletown
- Memorial Sloan Kettering Bergen, Montvale
RecruitingObservational studyHealthy volunteers welcome
Ages 18 and older · All sexes · Updated Feb 4, 2026 · NCT02099734From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.